Connection
Katja Kiseljak-Vassiliades to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Katja Kiseljak-Vassiliades has written about Drug Screening Assays, Antitumor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.682 |
|
|
|
-
Kar A, Wierman ME, Kiseljak-Vassiliades K. Update on in-vivo preclinical research models in adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes. 2020 06; 27(3):170-176.
Score: 0.652
-
Xiong W, Matheson CJ, Xu M, Backos DS, Mills TS, Salian-Mehta S, Kiseljak-Vassiliades K, Reigan P, Wierman ME. Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors. Mol Cancer Ther. 2016 Mar; 15(3):412-20.
Score: 0.030